Dr. Gottlieb is leading the agency through a collaborative management style, promoting longtime FDA veterans and filling other positions with former industry members. Agency employees told The Times he is an energetic and intense leader who holds “town hall-style meetings before making decisions,” according to the report.
Part of Dr. Gottlieb’s success also comes from his balanced efforts to protect public health, while also proposing rewards for drug and device companies.
“He’s being thoughtful; he’s being deliberative,” William Hubbard, a 30-year FDA veteran, now retired, told The Times. “He seems to be putting aside some of his more extreme rhetoric from when he was outside, and working through the issues with a public-health orientation.”
More articles on supply chain:
FDA OKs Novartis’ generic version of Teva’s MS drug: 3 things to know
Walgreens is reportedly in talks to purchase AmerisourceBergen: 7 things to know
Philips recalls HeartStart MRx Defibrillator: 3 things to know
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.